Stroke is the leading cause of neurological morbidity and mortality and the third leading cause of mortality worldwide. In spite of several advances over the past two decades in acute stroke management, stroke prevention and neuroprotection, there is no clear consensus in any of the areas of diagnosis and management. This book offers a rational approach to the current diagnosis and treatment of stroke that individual physicians can apply to their practice.Although PCCs have not shown improved outcome compared with FFP, there is a growing trend to use them instead of FFP.26, 27 This is largely ... rFVIIa, while rapidly reversing the INR, is not recommended as a sole agent for reversal of oral anticoagulation because it does not replenish all ... It remains unproven that rapidly reversing INR with PCCs after ICH reduces ICH growth or improves outcome.
|Title||:||Controversies in Stroke Care|
|Author||:||Majaz Moonis, M. V. Padma Srivastava|
|Publisher||:||Byword Books Private Limited - 2012-09-01|